Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Historical Holders from Q1 2014 to Q3 2025

Symbol
PBH on NYSE
Type / Class
Equity / Common Stock SH
Shares outstanding
49,246,014
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
50,990,641
Holdings value
$3,183,191,196
% of all portfolios
0%
Number of holders
348
Number of buys
163
Number of sells
-191
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.2% $609,115,318 7,524,587 BlackRock, Inc. 31 Mar 2025
ARIEL INVESTMENTS, LLC 7.3% +56% $224,325,442 +$86,900,237 3,594,959 +63% Ariel Investments, LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 5.9% $235,326,993 2,907,066 Dimensional Fund Advisors LP 31 Dec 2024
MACQUARIE GROUP LTD 4.67% $186,914,926 2,309,017 Macquarie Group Limited 31 Dec 2024

Institutional Holders of Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 50,990,641 $3,183,191,196 -$64,789,703 $62.4 348
2025 Q2 52,028,208 $4,154,947,022 +$68,664,201 $79.85 372
2025 Q1 51,179,850 $4,399,098,887 -$94,834,306 $85.97 354
2024 Q4 52,470,130 $4,096,580,344 +$88,611,492 $78.09 335
2024 Q3 51,041,422 $3,683,307,685 +$3,200,629 $72.1 323
2024 Q2 51,067,584 $3,515,715,953 -$4,889,638 $68.85 305
2024 Q1 51,320,692 $3,722,982,898 +$23,075,777 $72.56 311
2023 Q4 51,115,027 $3,129,318,451 +$6,370,695 $61.22 287
2023 Q3 50,946,303 $2,913,995,592 +$55,643,279 $57.19 279
2023 Q2 49,864,351 $2,965,000,913 -$29,425,137 $59.43 273
2023 Q1 50,365,220 $3,154,009,517 +$46,802,032 $62.63 280
2022 Q4 50,007,293 $3,131,794,375 +$2,107,559 $62.6 286
2022 Q3 50,088,729 $2,496,799,721 -$37,445,090 $49.83 270
2022 Q2 50,591,595 $2,974,240,060 +$45,867,050 $58.8 273
2022 Q1 50,360,901 $2,667,571,389 -$38,075,618 $52.94 269
2021 Q4 50,531,110 $3,065,040,827 -$86,724,122 $60.65 261
2021 Q3 50,742,397 $2,847,713,877 -$66,715,011 $56.11 240
2021 Q2 51,943,459 $2,706,851,067 -$30,851,217 $52.1 219
2021 Q1 52,622,155 $2,319,703,648 +$13,619,119 $44.08 233
2020 Q4 52,481,635 $1,830,396,086 -$33,067,279 $34.87 227
2020 Q3 53,391,500 $1,942,255,015 -$69,442,046 $36.42 233
2020 Q2 55,276,415 $2,075,158,514 +$31,352,635 $37.56 248
2020 Q1 54,484,428 $1,999,030,159 -$232,050,557 $36.68 242
2019 Q4 60,596,165 $2,454,518,932 +$57,809,287 $40.5 223
2019 Q3 60,663,941 $2,104,223,844 -$40,588,561 $34.69 223
2019 Q2 61,882,668 $1,958,581,043 -$77,895,459 $31.68 203
2019 Q1 64,684,131 $1,934,772,034 +$6,356,835 $29.91 212
2018 Q4 64,521,322 $1,992,028,340 -$29,177,570 $30.88 232
2018 Q3 65,339,093 $2,475,707,052 +$46,607,423 $37.89 228
2018 Q2 64,117,028 $2,460,757,189 -$15,816,343 $38.38 227
2018 Q1 64,996,481 $2,191,463,644 +$74,427,877 $33.72 231
2017 Q4 62,251,760 $2,764,599,700 +$158,390,917 $44.41 246
2017 Q3 58,228,273 $2,915,105,853 +$208,610,443 $50.09 237
2017 Q2 53,896,150 $2,846,183,578 +$96,584,892 $52.81 229
2017 Q1 52,703,516 $2,928,351,747 +$403,489,100 $55.56 237
2016 Q4 51,896,999 $2,703,733,392 -$16,514,792 $52.1 234
2016 Q3 52,282,326 $2,521,183,408 -$14,836,402 $48.27 241
2016 Q2 52,469,070 $2,907,447,728 -$24,211,465 $55.4 265
2016 Q1 53,494,813 $2,860,261,135 +$48,532,478 $53.39 255
2015 Q4 53,158,056 $2,735,865,931 +$7,030,794 $51.48 234
2015 Q3 53,012,021 $2,394,078,785 -$5,665,946 $45.16 205
2015 Q2 53,303,783 $2,464,727,142 -$24,046,662 $46.24 202
2015 Q1 53,965,137 $2,313,937,997 -$37,987,787 $42.89 192
2014 Q4 55,190,371 $1,916,059,210 +$23,933,344 $34.72 175
2014 Q3 54,685,532 $1,770,201,461 +$44,252,568 $32.37 174
2014 Q2 53,376,596 $1,807,875,895 +$43,025,450 $33.89 183
2014 Q1 52,192,219 $1,422,261,770 +$11,814,470 $27.25 167